Is it Time to Dump TherapeuticsMD Inc (TXMD) Stock After it Has Fallen 6.33% in a Week?

TherapeuticsMD Inc (TXMD) stock is lower by 6.33% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

TherapeuticsMD Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on TXMD!

See Full TXMD Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With TXMD Stock Today?

TherapeuticsMD Inc (TXMD) stock is trading at $2.07 as of 1:35 PM on Friday, Nov 10, a gain of $0.07, or 3.5% from the previous closing price of $2.00. The stock has traded between $2.00 and $2.36 so far today. Volume today is less active than usual. So far 13,004 shares have traded compared to average volume of 17,820 shares. To screen for more stocks like TherapeuticsMD Inc click here.

More About TherapeuticsMD Inc

TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates. Click Here to get the full Stock Report for TherapeuticsMD Inc stock.